Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 3;60(21):2850-2861.e8.
doi: 10.1016/j.devcel.2025.06.028. Epub 2025 Jul 17.

Jpx RNA controls Xist induction through spatial reorganization of the mouse X-inactivation center

Affiliations

Jpx RNA controls Xist induction through spatial reorganization of the mouse X-inactivation center

Hyun Jung Oh et al. Dev Cell. .

Abstract

Known to regulate chromosome looping on a genome-wide scale, the noncoding Jpx RNA was originally shown to control X chromosome counting and induce Xist expression during X chromosome inactivation (XCI). Not fully understood is how Jpx upregulates Xist in coordination with Tsix downregulation in cis. Here, by integrating epigenomic data and polymer modeling in a mouse embryonic stem cell model, we demonstrate that Jpx controls architectural and transcriptional dynamics within anti- and pro-XCI zones of the X-inactivation center. Distinct topological changes occur on the future active X (Xa) and inactive X (Xi) chromosomes. Jpx binds the enhancer of Tsix on the future Xi and alters loop formation to favor Xist induction, coordinately releasing CTCF from Tsix and Xist in cis on the future Xi. Thus, by controlling a dynamic rewiring of functional loops, Jpx flips a transcriptional switch to control mutually exclusive Tsix and Xist expression in cis.

Keywords: 3D genome structure; CTCF; Hi-C; Jpx RNA; X chromosome inactivation; X-inactivation center; XCI; Xist RNA; chromatin looping; epigenetics; loop extrusion.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.T.L. is a non-executive director of the GSK, a cofounder of Fulcrum Therapeutics, and a scientific advisor to Skyhawk Therapeutics.

References

    1. Lee JT (2011). Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control. Nat Rev Mol Cell Biol 12, 815–826. 10.1038/nrm3231. - DOI - PubMed
    1. Jegu T, Aeby E, and Lee JT (2017). The X chromosome in space. Nat Rev Genet 18, 377–389. 10.1038/nrg.2017.17. - DOI - PubMed
    1. da Rocha ST, and Heard E (2017). Novel players in X inactivation: insights into Xist-mediated gene silencing and chromosome conformation. Nat Struct Mol Biol 24, 197–204. 10.1038/nsmb.3370. - DOI - PubMed
    1. Disteche CM (2016). Dosage compensation of the sex chromosomes and autosomes. Semin Cell Dev Biol 56, 9–18. 10.1016/j.semcdb.2016.04.013. - DOI - PMC - PubMed
    1. Starmer J, and Magnuson T (2009). A new model for random X chromosome inactivation. Development 136, 1–10. 10.1242/dev.025908. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources